rs72552034
Variant names: 
Your query was ambiguous. Multiple possible variants found: 
Variant summary
Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_021098.3(CACNA1H):c.1047G>A(p.Ser349Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00014 in 1,612,250 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
 Genomes: 𝑓 0.00018   (  0   hom.,  cov: 33) 
 Exomes 𝑓:  0.00014   (  2   hom.  ) 
Consequence
 CACNA1H
NM_021098.3 synonymous
NM_021098.3 synonymous
Scores
 2
Clinical Significance
Conservation
 PhyloP100:  -8.07  
Publications
4 publications found 
Genes affected
 CACNA1H  (HGNC:1395):  (calcium voltage-gated channel subunit alpha1 H) This gene encodes a T-type member of the alpha-1 subunit family, a protein in the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization and consist of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. The alpha-1 subunit has 24 transmembrane segments and forms the pore through which ions pass into the cell. There are multiple isoforms of each of the proteins in the complex, either encoded by different genes or the result of alternative splicing of transcripts. Alternate transcriptional splice variants, encoding different isoforms, have been characterized for the gene described here. Studies suggest certain mutations in this gene lead to childhood absence epilepsy (CAE). [provided by RefSeq, Jul 2008] 
CACNA1H Gene-Disease associations (from GenCC):
- hyperaldosteronism, familial, type IVInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- childhood absence epilepsyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- epilepsy, childhood absence, susceptibility to, 6Inheritance: AD Classification: LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.74). 
BP6
Variant 16-1200499-G-A is Benign according to our data. Variant chr16-1200499-G-A is described in ClinVar as Likely_benign. ClinVar VariationId is 460038.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. 
BP7
Synonymous conserved (PhyloP=-8.07 with no splicing effect.
BS1
Variant frequency is greater than expected in population mid. GnomAdExome4 allele frequency = 0.000136 (198/1459944) while in subpopulation MID AF = 0.00694 (40/5766). AF 95% confidence interval is 0.00524. There are 2 homozygotes in GnomAdExome4. There are 103 alleles in the male GnomAdExome4 subpopulation. Median coverage is 34. This position passed quality control check. 
BS2
High AC in GnomAd4 at 27 AD gene. 
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt | 
|---|---|---|---|---|---|---|---|---|---|---|
| CACNA1H | ENST00000348261.11 | c.1047G>A | p.Ser349Ser | synonymous_variant | Exon 7 of 35 | 1 | NM_021098.3 | ENSP00000334198.7 | ||
| CACNA1H | ENST00000569107.6 | c.1047G>A | p.Ser349Ser | synonymous_variant | Exon 7 of 34 | 1 | ENSP00000454990.2 | |||
| CACNA1H | ENST00000711493.1 | c.1047G>A | p.Ser349Ser | synonymous_variant | Exon 7 of 34 | ENSP00000518778.1 | ||||
| CACNA1H | ENST00000565831.7 | c.1047G>A | p.Ser349Ser | synonymous_variant | Exon 7 of 34 | 1 | ENSP00000455840.1 | |||
| CACNA1H | ENST00000711450.1 | c.1047G>A | p.Ser349Ser | synonymous_variant | Exon 7 of 35 | ENSP00000518762.1 | ||||
| CACNA1H | ENST00000564231.6 | c.1047G>A | p.Ser349Ser | synonymous_variant | Exon 7 of 35 | 1 | ENSP00000457555.2 | |||
| CACNA1H | ENST00000638323.1 | c.1008G>A | p.Ser336Ser | synonymous_variant | Exon 7 of 35 | 5 | ENSP00000492267.1 | |||
| CACNA1H | ENST00000562079.6 | c.1047G>A | p.Ser349Ser | synonymous_variant | Exon 7 of 34 | 1 | ENSP00000454581.2 | |||
| CACNA1H | ENST00000711438.1 | c.1008G>A | p.Ser336Ser | synonymous_variant | Exon 7 of 34 | ENSP00000518754.1 | ||||
| CACNA1H | ENST00000711482.1 | c.1047G>A | p.Ser349Ser | synonymous_variant | Exon 7 of 36 | ENSP00000518771.1 | ||||
| CACNA1H | ENST00000711485.1 | c.1047G>A | p.Ser349Ser | synonymous_variant | Exon 7 of 35 | ENSP00000518774.1 | ||||
| CACNA1H | ENST00000711455.1 | c.1047G>A | p.Ser349Ser | synonymous_variant | Exon 7 of 36 | ENSP00000518768.1 | ||||
| CACNA1H | ENST00000711483.1 | c.1047G>A | p.Ser349Ser | synonymous_variant | Exon 7 of 35 | ENSP00000518772.1 | ||||
| CACNA1H | ENST00000711456.1 | c.1047G>A | p.Ser349Ser | synonymous_variant | Exon 7 of 34 | ENSP00000518769.1 | ||||
| CACNA1H | ENST00000621827.2 | n.1047G>A | non_coding_transcript_exon_variant | Exon 7 of 37 | 6 | ENSP00000518766.1 | ||||
| CACNA1H | ENST00000637236.3 | n.1047G>A | non_coding_transcript_exon_variant | Exon 7 of 34 | 5 | ENSP00000492650.2 | ||||
| CACNA1H | ENST00000639478.1 | n.1047G>A | non_coding_transcript_exon_variant | Exon 7 of 35 | 5 | ENSP00000491945.1 | ||||
| CACNA1H | ENST00000640028.1 | n.1047G>A | non_coding_transcript_exon_variant | Exon 7 of 35 | 5 | ENSP00000491488.1 | ||||
| CACNA1H | ENST00000711442.1 | n.*494G>A | non_coding_transcript_exon_variant | Exon 6 of 34 | ENSP00000518758.1 | |||||
| CACNA1H | ENST00000711448.1 | n.1047G>A | non_coding_transcript_exon_variant | Exon 7 of 36 | ENSP00000518760.1 | |||||
| CACNA1H | ENST00000711449.1 | n.1047G>A | non_coding_transcript_exon_variant | Exon 7 of 35 | ENSP00000518761.1 | |||||
| CACNA1H | ENST00000711451.1 | n.1047G>A | non_coding_transcript_exon_variant | Exon 7 of 36 | ENSP00000518763.1 | |||||
| CACNA1H | ENST00000711452.1 | n.1047G>A | non_coding_transcript_exon_variant | Exon 7 of 36 | ENSP00000518764.1 | |||||
| CACNA1H | ENST00000711453.1 | n.1047G>A | non_coding_transcript_exon_variant | Exon 7 of 36 | ENSP00000518765.1 | |||||
| CACNA1H | ENST00000711484.1 | n.1047G>A | non_coding_transcript_exon_variant | Exon 7 of 35 | ENSP00000518773.1 | |||||
| CACNA1H | ENST00000711486.1 | n.1047G>A | non_coding_transcript_exon_variant | Exon 7 of 37 | ENSP00000518775.1 | |||||
| CACNA1H | ENST00000711487.1 | n.1047G>A | non_coding_transcript_exon_variant | Exon 7 of 36 | ENSP00000518776.1 | |||||
| CACNA1H | ENST00000711488.1 | n.1047G>A | non_coding_transcript_exon_variant | Exon 7 of 35 | ENSP00000518777.1 | |||||
| CACNA1H | ENST00000711442.1 | n.*494G>A | 3_prime_UTR_variant | Exon 6 of 34 | ENSP00000518758.1 | 
Frequencies
GnomAD3 genomes  0.000177  AC: 27AN: 152188Hom.:  0  Cov.: 33 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
27
AN: 
152188
Hom.: 
Cov.: 
33
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD2 exomes  AF:  0.000142  AC: 35AN: 246924 AF XY:  0.000149   show subpopulations 
GnomAD2 exomes 
 AF: 
AC: 
35
AN: 
246924
 AF XY: 
Gnomad AFR exome 
 AF: 
Gnomad AMR exome 
 AF: 
Gnomad ASJ exome 
 AF: 
Gnomad EAS exome 
 AF: 
Gnomad FIN exome 
 AF: 
Gnomad NFE exome 
 AF: 
Gnomad OTH exome 
 AF: 
GnomAD4 exome  AF:  0.000136  AC: 198AN: 1459944Hom.:  2  Cov.: 34 AF XY:  0.000142  AC XY: 103AN XY: 726276 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
198
AN: 
1459944
Hom.: 
Cov.: 
34
 AF XY: 
AC XY: 
103
AN XY: 
726276
show subpopulations 
African (AFR) 
 AF: 
AC: 
4
AN: 
33470
American (AMR) 
 AF: 
AC: 
5
AN: 
44708
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
7
AN: 
26108
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
39692
South Asian (SAS) 
 AF: 
AC: 
10
AN: 
86256
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
51904
Middle Eastern (MID) 
 AF: 
AC: 
40
AN: 
5766
European-Non Finnish (NFE) 
 AF: 
AC: 
115
AN: 
1111702
Other (OTH) 
 AF: 
AC: 
17
AN: 
60338
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.481 
Heterozygous variant carriers
 0 
 11 
 22 
 34 
 45 
 56 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
 0 
 10 
 20 
 30 
 40 
 50 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome  0.000177  AC: 27AN: 152306Hom.:  0  Cov.: 33 AF XY:  0.000201  AC XY: 15AN XY: 74480 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
27
AN: 
152306
Hom.: 
Cov.: 
33
 AF XY: 
AC XY: 
15
AN XY: 
74480
show subpopulations 
African (AFR) 
 AF: 
AC: 
9
AN: 
41552
American (AMR) 
 AF: 
AC: 
2
AN: 
15306
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
3472
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
5170
South Asian (SAS) 
 AF: 
AC: 
1
AN: 
4830
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
10630
Middle Eastern (MID) 
 AF: 
AC: 
2
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
11
AN: 
68028
Other (OTH) 
 AF: 
AC: 
2
AN: 
2112
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.501 
Heterozygous variant carriers
 0 
 2 
 3 
 5 
 6 
 8 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Variant carriers
 0 
 2 
 4 
 6 
 8 
 10 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
EpiCase 
 AF: 
EpiControl 
 AF: 
ClinVar
Significance: Likely benign 
Submissions summary: Benign:2 
Revision: criteria provided, multiple submitters, no conflicts
LINK: link 
Submissions by phenotype
Idiopathic generalized epilepsy;C4310756:Hyperaldosteronism, familial, type IV    Benign:1 
Oct 14, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided    Benign:1 
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.